A, F., JL, K., SS, T., VS, P., IK, B., BM, B., . . . JN, L. (2025). The Literature that Commercial Insurance Payers Use to Substantiate Knee Osteochondral Allograft Policies Are of a Low Level of Evidence. Cartilage, 16(3), 280. https://doi.org/10.1177/19476035241276859
Chicago Style (17th ed.) CitationA, Fathi, et al. "The Literature That Commercial Insurance Payers Use to Substantiate Knee Osteochondral Allograft Policies Are of a Low Level of Evidence." Cartilage 16, no. 3 (2025): 280. https://doi.org/10.1177/19476035241276859.
MLA (9th ed.) CitationA, Fathi, et al. "The Literature That Commercial Insurance Payers Use to Substantiate Knee Osteochondral Allograft Policies Are of a Low Level of Evidence." Cartilage, vol. 16, no. 3, 2025, p. 280, https://doi.org/10.1177/19476035241276859.